Pradeep Chaluvally-Raghavan: Curious about Cancer

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

Written byJef Akst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

KANG JIN JEONGGrowing up in a small village in India, “I was really passionate to know why things work,” recalls Pradeep Chaluvally-Raghavan. “Very silly and very basic questions” like: Why do plants grow? In college, his questions became more focused. “I wanted to study in a higher-resolution manner why living beings are growing and what kind of mechanism is regulating the growth of the cell,” Chaluvally-Raghavan says. “Then I was really interested to learn more about cancer, because cancer is a kind of unlimited growth.”

After obtaining undergraduate and master’s degrees in biology, he began his PhD work in the lab of Girija Kuttan at the Amala Cancer Research Center of the University of Calicut in India’s Kerala state. There, he began exploring the role of the NF-κB transcription factor and proinflammatory cytokines in the metastasis of melanoma using mouse models, screening for natural compounds that might help treat the cancer. He discovered, for example, that piperine, the molecule that gives black pepper its punch, inhibited metastasis in vitro.1

After earning his PhD, Chaluvally-Raghavan dove even deeper into cancer research in the lab of Yosef Yarden at the Weizmann Institute of Science in Israel, where he developed a 3-D cell culture model to study the HER2 oncogene, which is overexpressed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies